ASX-listed Nutritional Growth up on starting trials for sports supplement

Nutritional Growth Solutions

11/01/2023 02:58

** Shares of ASX-listed Nutritional Growth Solutions
 NGS.AX  rise as much as 5.3% to A$0.060- hitting their highest
since Dec.29, 2022
    ** Israel-based child nutrition brand says it has started
clinical trials to evaluate the effect of it's sports supplement
on the physical activity performance of young soccer players
    ** Says trial will be done across 50 healthy soccer players
aged 8-15 years old to determine efficacy and safety of the new
supplement versus placebo
    ** Adds results of the clinical trial are expected in Q3
2023              
    ** Stock fell 67.6% in 2022 
 (Reporting by Nausheen Thusoo in Bengaluru)
 ((Nausheen.Thusoo@thomsonreuters.com;))